Summary:
The purpose of the study is compare different administration of Dulera (combo) vs Dulera (monotherapy) in adults and children greater than 12 years old. Dulera is approved by the FDA for the treatment of asthma.
Qualified Participants Must:
• Must be 12 years of age and older
•
Have asthma that is not well-controlled.
•
Have had at least one exacerbation within the last year
Qualified Participants May Receive:
• Study-related medical exams at no cost
• Study-related medication (Dulera) at no cost and (Albuterol and Prednisone, in event of exacerbation)
• Compensation may be available